Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Human|
|Published species reactivity||Primate, Human, Mouse|
|Host / Isotype||Rabbit / IgG|
|Immunogen||Recombinant human vimentin protein.|
|Storage buffer||tissue culture supernatant diluted in TBS, pH 7.5, with 1% BSA|
|Contains||<0.1% sodium azide|
|Storage Conditions||4° C, do not freeze|
|Tested Applications||Dilution *|
|Flow Cytometry (Flow)||1:100|
|Immunohistochemistry (Paraffin) (IHC (P))||1:200|
|Western Blot (WB)||1:100|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
A suggested positive control is melanomas or sarcomas.
This gene encodes a member of the intermediate filament family. Intermediate filamentents, along with microtubules and actin microfilaments, make up the cytoskeleton. The protein encoded by this gene is responsible for maintaining cell shape, integrity of the cytoplasm, and stabilizing cytoskeletal interactions. It is also involved in the immune response, and controls the transport of low-density lipoprotein (LDL)-derived cholesterol from a lysosome to the site of esterification. It functions as an organizer of a number of critical proteins involved in attachment, migration, and cell signaling. Mutations in this gene causes a dominant, pulverulent cataract.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
A systematic analysis of commonly used antibodies in cancer diagnostics.
MA5-16409 was used in immunohistochemistry to perform a systematic study of the diagnostic power of a range of antibodies commonly used in the diagnosis of cancer
|Gremel G,Bergman J,Djureinovic D,Edqvist PH,Maindad V,Bharambe BM,Khan WA,Navani S,Elebro J,Jirström K,Hellberg D,Uhlén M,Micke P,Pontén F||Histopathology (64:293)||2014|
Molecular Magnetic Resonance Imaging of Tumors with a PTPµ Targeted Contrast Agent.
MA5-16409 was used in immunohistochemistry to develop a molecular MRI methodology utilizing a contrast agent that targets transmembrane PTPmu
|Burden-Gulley SM,Zhou Z,Craig SE,Lu ZR,Brady-Kalnay SM||Translational oncology (6:329)||2013|
Donor cornea transfer from Optisol GS to organ culture storage: a two-step procedure to increase donor tissue lifespan.
MA5-16409 was used in immunohistochemistry to study the effect of transfer from Optisol-GS to organ culture storage of the lifespan of donor corneas
|Haug K,Azqueta A,Johnsen-Soriano S,Shahdadfar A,Drolsum LK,Moe MC,Røger MT,Romero FJ,Collins AR,Nicolaissen B||Acta ophthalmologica (91:219)||2013|
Podoplanin expressing cancer associated fibroblasts are associated with unfavourable prognosis in adenocarcinoma of the esophagus.
MA5-16409 was used in immunohistochemistry to study the role and prognostic value of cancer associated fibroblasts expressing podoplanin in esophageal adenocarcinoma
|Schoppmann SF,Jesch B,Riegler MF,Maroske F,Schwameis K,Jomrich G,Birner P||Clinical & experimental metastasis (30:441)||2013|
Medulloblastoma with focal divergent/teratoid differentiation.
MA5-16409 was used in immunohistochemistry to study medulloblastoma with focal divergent/teratoid differentiation
|Majumdar K,Tyagi I,Saran RK,Sakhuja P,Sharma A||Brain tumor pathology (30:50)||2013|
Mucinous epithelial lesions in endometrial curettage material: a diagnostic challenge.
MA5-16409 was used in immunohistochemistry to study the diagnostic challenge of distinguishing benign and malignant mucinous lesions obtained at endometrial curretage
|Pavlakis K,Vrekoussis T,Messini I,Voulgaris Z,Chrysanthakis D,Yiannou P,Stofas A,Panoskaltsis T||Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry (20:607)||2012|
Residual tumor cells that drive disease relapse after chemotherapy do not have enhanced tumor initiating capacity.
MA5-16409 was used in immunohistochemistry to study the tumor-initiating capacity of the residual cells responsible for relapse following chemotherapy using non-small cell lung cancer as a model system
|Hegde GV,de la Cruz C,Eastham-Anderson J,Zheng Y,Sweet-Cordero EA,Jackson EL||PloS one (7:null)||2012|
Immunohistochemical characterization of nonhuman primate ovarian sex cord-stromal tumors.
MA5-16409 was used in immunohistochemistry to study the immunohistochemistry of nonhuman primate ovarian sex cord-stromal tumors
|Durkes A,Garner M,Juan-Sallés C,Ramos-Vara J||Veterinary pathology (49:834)||2012|
Gonadoblastoma in the ovaries of a lesser galago (Galago senegalensis braccatus).
MA5-16409 was used in immunohistochemistry to report on a case of gonadoblastoma in the ovaries of a lesser galago
|Irizarry Rovira AR,Lynch S,David M,Ramos Vara JA||Journal of comparative pathology (147:204)||2012|
Sporadic haemangioblastoma of the kidney with rhabdoid features and focal CD10 expression: report of a case and literature review.
MA5-16409 was used in immunohistochemistry to report on a case of sporadic haemangioblastoma of the kidney with rhabdoid features and focal CD10 expression
|Yin WH,Li J,Chan JK||Diagnostic pathology (7:null)||2012|
Cadherin-11, a marker of the mesenchymal phenotype, regulates glioblastoma cell migration and survival in vivo.
MA5-16409 was used in immunohistochemistry to study the expression cadherin-11 in glioblastoma cell lines and its role in cell migration and survival in xenograft models
|Kaur H,Phillips-Mason PJ,Burden-Gulley SM,Kerstetter-Fogle AE,Basilion JP,Sloan AE,Brady-Kalnay SM||Molecular cancer research : MCR (10:293)||2012|
Cotyledonoid leiomyoma of uterus: a case report.
MA5-16409 was used in immunohistochemistry to report on a case of cotyledonoid leiomyoma of uterus
|Ersöz S,Turgutalp H,Mungan S,Güvendı G,Güven S||Tu¿rk patoloji dergisi (27:257)||2011|
Primary myoepithelial carcinoma of the larynx: case report and review of the literature.
MA5-16409 was used in immunohistochemistry to report on a case of primary myoepithelial carcinoma of the larynx
|Yu G,Qu G,Kong L,Pan X,Wang W,Lv J||Pathology, research and practice (207:127)||2011|
A novel assessment of the quality of immunohistostaining overcomes the limitations of current methods.
MA5-16409 was used in immunohistochemistry to establish a straightforward procedure for objective quality evaluation of the components involved in immunohistostaining
|Eisenthal A,Trejo L,Shtabsky A,Bedny F,Brazowski E||Pathology, research and practice (204:323)||2008|
Basal-HER2 phenotype shows poorer survival than basal-like phenotype in hormone receptor-negative invasive breast cancers.
MA5-16409 was used in immunohistochemistry to study the prognostic features of basal-like breast tumors in a series of hormone receptor-negative invasive breast cancer tumors
|Liu H,Fan Q,Zhang Z,Li X,Yu H,Meng F||Human pathology (39:167)||2008|
Laparoscopic resection of urinary bladder paraganglioma: a case report.
MA5-16409 was used in immunohistochemistry to report on a case of aparoscopic resection of urinary bladder paraganglioma
|Dilbaz B,Bayoglu Y,Oral S,Cavusoglu D,Uluoglu O,Dilbaz S||Surgical laparoscopy, endoscopy & percutaneous techniques (16:58)||2006|
Nek8 mutation causes overexpression of galectin-1, sorcin, and vimentin and accumulation of the major urinary protein in renal cysts of jck mice.
MA5-16409 was used in immunohistochemistry to study the effect of Nek8 mutation on protein expression and accumulation in renal cysts of jck mice
|Valkova N,Yunis R,Mak SK,Kang K,Kültz D||Molecular & cellular proteomics : MCP (4:1009)||2005|
Multiple types of data are required to identify the mechanisms influencing the spatial expansion of melanoma cell colonies.
MA5-16409 was used in immunocytochemistry to use a combination of experimental data and mathematical modeling to study the spacial expansion of melanoma cells
|Treloar KK,Simpson MJ,Haridas P,Manton KJ,Leavesley DI,McElwain DL,Baker RE||BMC systems biology (7:null)||2013|
Pancreatic cancer-associated stellate cells promote differentiation of myeloid-derived suppressor cells in a STAT3-dependent manner.
MA5-16409 was used in immunocytochemistry to study the role of STAT3 in the mechanism by which stellate cells associated with pancreatic cancer promote the differentiation of myeloid-derived suppressor cells
|Mace TA,Ameen Z,Collins A,Wojcik S,Mair M,Young GS,Fuchs JR,Eubank TD,Frankel WL,Bekaii-Saab T,Bloomston M,Lesinski GB||Cancer research (73:3007)||2013|
Knock-down of plasminogen-activator inhibitor-1 enhances expression of E-cadherin and promotes epithelial differentiation of human pancreatic adenocarcinoma cells.
MA5-16409 was used in immunocytochemistry to study the increased E-cadherin expression and epithelial differentiation of human pancreatic carcinoma cells in response to PAI-1 deletion
|Lupu-Meiri M,Geras-Raaka E,Lupu R,Shapira H,Sandbank J,Segal L,Gershengorn MC,Oron Y||Journal of cellular physiology (227:3621)||2012|
Derivation of myoepithelial progenitor cells from bipotent mammary stem/progenitor cells.
MA5-16409 was used in western blot to derive myoepithelial progenitor cells from bipotent mammary stem/progenitor cells.
|Zhao X,Malhotra GK,Band H,Band V||PloS one (7:null)||2012|
epididymis luminal protein 113; FLJ36605; VIM
CTRCT30; HEL113; VIM